PT3824876T - Long-acting formulations of insulins - Google Patents

Long-acting formulations of insulins

Info

Publication number
PT3824876T
PT3824876T PT201999406T PT20199940T PT3824876T PT 3824876 T PT3824876 T PT 3824876T PT 201999406 T PT201999406 T PT 201999406T PT 20199940 T PT20199940 T PT 20199940T PT 3824876 T PT3824876 T PT 3824876T
Authority
PT
Portugal
Prior art keywords
insulins
long
acting formulations
formulations
acting
Prior art date
Application number
PT201999406T
Other languages
Portuguese (pt)
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of PT3824876T publication Critical patent/PT3824876T/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
PT201999406T 2011-02-10 2011-05-17 Long-acting formulations of insulins PT3824876T (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11305140 2011-02-10

Publications (1)

Publication Number Publication Date
PT3824876T true PT3824876T (en) 2023-05-18

Family

ID=43769093

Family Applications (1)

Application Number Title Priority Date Filing Date
PT201999406T PT3824876T (en) 2011-02-10 2011-05-17 Long-acting formulations of insulins

Country Status (1)

Country Link
PT (1) PT3824876T (en)

Similar Documents

Publication Publication Date Title
IL251318A0 (en) Long-acting formulations of insulins
RS60432B1 (en) Use of long-acting glp-1 peptides
TWI561242B (en) Long-acting peptide analogs
HK1256641A1 (en) Long-acting injectable moxidectin formulations
EP2755680A4 (en) Particluate vaccine formulations
IL229700A0 (en) Darunavir formulations
HK1203355A1 (en) Uses of 4-desferrithiocin analogs 4-
EP2684869A4 (en) Preparation of 3-mercaptopropionates
IL230977A (en) Crystalline form of rilapladib
GB201110278D0 (en) Formulations
PT3824876T (en) Long-acting formulations of insulins
HUE049152T2 (en) Use of long-acting glp-1 peptides
GB201111578D0 (en) Pharmeutical formulations
GB201111013D0 (en) Formulations
GB201107627D0 (en) Formulations
GB201107626D0 (en) Formulations
GB201105410D0 (en) Formulations
GB201105360D0 (en) Formulations
GB201104049D0 (en) Formulations
GB201104048D0 (en) Formulations
GB201102795D0 (en) Formulations